BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 21509908)

  • 1. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease.
    Vavricka SR; Spigaglia SM; Rogler G; Pittet V; Michetti P; Felley C; Mottet C; Braegger CP; Rogler D; Straumann A; Bauerfeind P; Fried M; Schoepfer AM;
    Inflamm Bowel Dis; 2012 Mar; 18(3):496-505. PubMed ID: 21509908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Diagnostic Delay and Associated Factors on Clinical Outcomes in a U.S. Inflammatory Bowel Disease Cohort.
    Nguyen VQ; Jiang D; Hoffman SN; Guntaka S; Mays JL; Wang A; Gomes J; Sorrentino D
    Inflamm Bowel Dis; 2017 Oct; 23(10):1825-1831. PubMed ID: 28885229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort.
    Hiroz P; Vavricka SR; Fournier N; Safroneeva E; Pittet V; Rogler G; Schoepfer AM;
    Scand J Gastroenterol; 2014 Oct; 49(10):1207-18. PubMed ID: 25120029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Delay in Romanian Patients with Inflammatory Bowel Disease: Risk Factors and Impact on the Disease Course and Need for Surgery.
    Zaharie R; Tantau A; Zaharie F; Tantau M; Gheorghe L; Gheorghe C; Gologan S; Cijevschi C; Trifan A; Dobru D; Goldis A; Constantinescu G; Iacob R; Diculescu M;
    J Crohns Colitis; 2016 Mar; 10(3):306-14. PubMed ID: 26589956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Evaluation of Diagnostic Delay in Pediatric Inflammatory Bowel Disease.
    Schoepfer AM; Vavricka S; Safroneeva E; Fournier N; Manser C; Frei P; Deltenre P; Rogler G; Straumann A; Ezri J; Nydegger A; Braegger C
    J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):245-247. PubMed ID: 27101540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort.
    Alatri A; Schoepfer A; Fournier N; Engelberger RP; Safroneeva E; Vavricka S; Biedermann L; Calanca L; Mazzolai L;
    Scand J Gastroenterol; 2016 Oct; 51(10):1200-5. PubMed ID: 27211077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childlessness in Patients with Inflammatory Bowel Disease - Data from the Prospective Multi-center Swiss IBD Cohort Study.
    Sulz MC; Doulberis M; Fournier N; Biedermann L; Zeitz J; Misselwitz B; Imthurn B; Rogler G;
    J Gastrointestin Liver Dis; 2023 Dec; 32(4):460-468. PubMed ID: 38147613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease.
    Long MD; Kappelman MD; Martin CF; Chen W; Anton K; Sandler RS
    J Clin Gastroenterol; 2016 Feb; 50(2):152-6. PubMed ID: 26485106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).
    Henriksen M; Jahnsen J; Lygren I; Sauar J; Schulz T; Stray N; Vatn MH; Moum B;
    Scand J Gastroenterol; 2006 Sep; 41(9):1037-43. PubMed ID: 16938716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery.
    Lee DW; Koo JS; Choe JW; Suh SJ; Kim SY; Hyun JJ; Jung SW; Jung YK; Yim HJ; Lee SW
    World J Gastroenterol; 2017 Sep; 23(35):6474-6481. PubMed ID: 29085197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic delay in Canadian children with inflammatory bowel disease is more common in Crohn's disease and associated with decreased height.
    Ricciuto A; Fish JR; Tomalty DE; Carman N; Crowley E; Popalis C; Muise A; Walters TD; Griffiths AM; Church PC
    Arch Dis Child; 2018 Apr; 103(4):319-326. PubMed ID: 28794097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
    Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
    World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center.
    Szántó K; Nyári T; Bálint A; Bor R; Milassin Á; Rutka M; Fábián A; Szepes Z; Nagy F; Molnár T; Farkas K
    PLoS One; 2018; 13(7):e0200824. PubMed ID: 30059523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
    Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
    Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic analysis of annual health resource utilization and costs in hospitalized patients with inflammatory bowel disease in Switzerland.
    Schoepfer A; Vavricka SR; Brüngger B; Reich O; Blozik E; Bähler C
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):868-875. PubMed ID: 29757772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crohn's-like clinical and pathological manifestations of giant inflammatory polyposis in IBD: a potential diagnostic pitfall.
    Naymagon S; Mikulasovich M; Gui X; Ullman TA; Harpaz N
    J Crohns Colitis; 2014 Jul; 8(7):635-40. PubMed ID: 24368253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil.
    Parente JM; Coy CS; Campelo V; Parente MP; Costa LA; da Silva RM; Stephan C; Zeitune JM
    World J Gastroenterol; 2015 Jan; 21(4):1197-206. PubMed ID: 25632193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.